Search research articles
Contact Us
Filters
Showing results (81-90 of 169) with videos related to
Page
of 17
Sort By:
Prostaglandins
|
June 1, 1980
Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries
M F Gimeno, L Sterin-Borda, E S Borda, et al.
Thrombosis Research
|
September 7, 2005
Endogenous or exogenous coagulation factor level and the response to activated protein C
Laura C Gennari, Alicia N Blanco, Maria P Domínguez, et al.
Bone
|
May 12, 2012
Circulating sclerostin is elevated in short-term and reduced in long-term SCI
Ricardo A Battaglino, Supreetha Sudhakar, Antonio A Lazzari, et al.
Medicina
|
January 1, 1986
[Release reaction in Glanzmann thrombasthenia]
M A Schattner, S S Meschengieser, A C Kempfer, et al.
Thrombosis and Haemostasis
|
January 1, 1997
Enhanced response to chemotactic activation of polymorphonuclear leukocytes from patients with heart valve replacement
N Maugeri, A C Kempfer, V Evangelista, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
January 1, 1983
The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material"
E S Borda, L Sterin-Borda, M F Gimeno, et al.
American Journal of Hematology
|
March 8, 2000
Bleeding risk factors in chronic oral anticoagulation with acenocoumarol
P Casais, A Sánchez Luceros, S Meschengieser, et al.
Thrombosis Research
|
November 26, 1999
The effect of polyclonal antibody against fibronectin on von Willebrand Factor multimeric size
A C Kempfer, C E Farías, G A Carballo, et al.
Hematology (Amsterdam, Netherlands)
|
April 18, 2012
Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis
M A Lazzari, A Sanchez-Luceros, A I Woods, et al.
Thrombosis Research
|
November 1, 1987
Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disorders
S Meschengieser, A Blanco, A Woods, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 169) with videos related to
Sort By:
Page
of 17
Prostaglandins
|
June 1, 1980
Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries
M F Gimeno, L Sterin-Borda, E S Borda, et al.
Thrombosis Research
|
September 7, 2005
Endogenous or exogenous coagulation factor level and the response to activated protein C
Laura C Gennari, Alicia N Blanco, Maria P Domínguez, et al.
Bone
|
May 12, 2012
Circulating sclerostin is elevated in short-term and reduced in long-term SCI
Ricardo A Battaglino, Supreetha Sudhakar, Antonio A Lazzari, et al.
Medicina
|
January 1, 1986
[Release reaction in Glanzmann thrombasthenia]
M A Schattner, S S Meschengieser, A C Kempfer, et al.
Thrombosis and Haemostasis
|
January 1, 1997
Enhanced response to chemotactic activation of polymorphonuclear leukocytes from patients with heart valve replacement
N Maugeri, A C Kempfer, V Evangelista, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
January 1, 1983
The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material"
E S Borda, L Sterin-Borda, M F Gimeno, et al.
American Journal of Hematology
|
March 8, 2000
Bleeding risk factors in chronic oral anticoagulation with acenocoumarol
P Casais, A Sánchez Luceros, S Meschengieser, et al.
Thrombosis Research
|
November 26, 1999
The effect of polyclonal antibody against fibronectin on von Willebrand Factor multimeric size
A C Kempfer, C E Farías, G A Carballo, et al.
Hematology (Amsterdam, Netherlands)
|
April 18, 2012
Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis
M A Lazzari, A Sanchez-Luceros, A I Woods, et al.
Thrombosis Research
|
November 1, 1987
Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disorders
S Meschengieser, A Blanco, A Woods, et al.
Page
of 17